Sanofi (NASDAQ:SNY) Alliance Bernstein 37th Annual Strategic Decisions Conference June 2, 2021 11:00 AM ET
Company Participants
Jean-Baptiste de Chatillon – Executive Vice President and Chief Financial Officer
Eva Schaefer-Jansen – Head-Investor Relations
Conference Call Participants
Wimal Kapadia – Bernstein
Wimal Kapadia
So good morning, and good afternoon, everyone. Thank you for joining today. I am Wimal Kapadia, the EU biopharma analyst at Bernstein. And today is my great pleasure to have with us, Jean-Baptiste de Chatillon, CFO of Sanofi for a fireside chat. So thank you for joining Jean-Baptiste that we very much appreciate your time today.
So as a reminder, you are able to submit questions by the Q&A – live Q&A tab on the right hand side of your viewing screen. If you are facing technical difficulties, please do contact investor access or your sales contact. Nice to see we have several questions already from the audience on the pigeonhole. So that's a nice interactive session we've got going. So before we kick off the Q&A, I hand over to Jean-Baptiste to make a few introductory remarks. So over to you, Jean-Baptiste.
Jean-Baptiste de Chatillon
Thank you, Wimal. Thank you all of you for joining today. It's really my pleasure to share with you what we do in Sanofi. I won't be longer on an introduction. We said where we wanted to go in December 2019. Many things happened since then, but we really try to deliver on our targets. We form a team which is really committed to deliver on those targets. And we start seeing some proof points coming nicely quarter-after-quarter. Never could always be quicker, but we know that we are working also for the long-term and deliver this extra gross level coming in the second part of the plan and that's what we are here for. And we always tried to make room to be
- Read more current SNY analysis and news
- View all earnings call transcripts